help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2006-2394
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
92/5/1934    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Toledo, R. A.
Right arrow Articles by Dahia, P. L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Toledo, R. A.
Right arrow Articles by Dahia, P. L. M.
Related Collections
Right arrow Diabetes and Insulin
Right arrow Endocrine Oncology
The Journal of Clinical Endocrinology & Metabolism Vol. 92, No. 5 1934-1937
Copyright © 2007 by The Endocrine Society

Germline Mutation in the Aryl Hydrocarbon Receptor Interacting Protein Gene in Familial Somatotropinoma

Rodrigo A. Toledo, Delmar M. Lourenço, Jr., Bernardo Liberman, Malebranche B. C. Cunha-Neto, Maria G. Cavalcanti, Cinthia B. Moyses, Sergio P. A. Toledo and Patricia L. M. Dahia

Unidade de Endocrinologia Genética LIM-25, Endocrinologia (R.A.T., D.M.L., M.G.C., C.B.M., S.P.A.T.) and Neuroendocrine Unit (M.B.C.C.-N.), Division of Neurosurgery, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo 01246-903, Brazil; Hospital Brigadeiro (B.L.), São Paulo 04107-030, Brazil; and Departments of Medicine and Cellular and Structural Biology (P.L.M.D.), San Antonio Cancer Institute, University of Texas Health Science Center, San Antonio, Texas 78229

Address all correspondence and requests for reprints to: Sergio Toledo, Unidade de Endocrinologia Genética, Av Dr Arnaldo 455-5° andar, São Paulo-SP, Brazil 01246-903. E-mail: toldo{at}usp.br; or Patricia Dahia, Department of Medicine, University of Texas Health Science Center, San Antonio, 7703 Floyd Curl Drive, MC 7880, San Antonio, Texas 78229. E-mail: dahia{at}uthscsa.edu.

Context: Acromegaly is usually sporadic, but familial cases occur in association with several familial pituitary tumor syndromes. Recently mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene were associated with familial pituitary adenoma predisposition.

Objective: The objective of the study was to investigate the status of AIP in a pituitary tumor predisposition family.

Settings: The study was conducted at a nonprofit academic center and medical centers.

Patients: Eighteen members of a Brazilian family with acromegaly were studied.

Results: A novel germline mutation in the AIP gene, Y268X, predicted to generate a protein lacking two conserved domains, was identified in four members of this family: two siblings with early-onset acromegaly; a third, 41-yr-old sibling with a microadenoma but no clinical features of disease, and his 3-yr-old son. No changes were found in 14 unaffected at-risk relatives or 92 healthy controls.

Conclusions: We confirm the role of the AIP gene in familial acromegaly. This finding increases the spectrum of molecular defects that can give rise to pituitary adenoma susceptibility. Establishment of genotype-phenotype correlations in AIP mutant tumors will determine whether AIP screening can be used as a tool for clinical surveillance and genetic counseling of families with pituitary tumor predisposition. The underlying basis for the phenotypic variation within AIP-mutant families and the mechanism of AIP-mediated tumorigenesis remain to be defined.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
C. A. Leontiou, M. Gueorguiev, J. van der Spuy, R. Quinton, F. Lolli, S. Hassan, H. S. Chahal, S. C. Igreja, S. Jordan, J. Rowe, et al.
The Role of the Aryl Hydrocarbon Receptor-Interacting Protein Gene in Familial and Sporadic Pituitary Adenomas
J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2390 - 2401.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Melmed
Update in Pituitary Disease
J. Clin. Endocrinol. Metab., February 1, 2008; 93(2): 331 - 338.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
A. Beckers and A. F Daly
The clinical, pathological, and genetic features of familial isolated pituitary adenomas
Eur. J. Endocrinol., October 1, 2007; 157(4): 371 - 382.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
L. A Naves, A. F Daly, J.-F. Vanbellinghen, L. A Casulari, C. Spilioti, A. V Magalhaes, M. F Azevedo, L. A Giacomini, P. P Nascimento, R. O Nunes, et al.
Variable pathological and clinical features of a large Brazilian family harboring a mutation in the aryl hydrocarbon receptor-interacting protein gene
Eur. J. Endocrinol., October 1, 2007; 157(4): 383 - 391.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
A Raitila, M Georgitsi, A Karhu, K Tuppurainen, M J Makinen, K Birkenkamp-Demtroder, K Salmenkivi, T F Orntoft, J Arola, V Launonen, et al.
No evidence of somatic aryl hydrocarbon receptor interacting protein mutations in sporadic endocrine neoplasia
Endocr. Relat. Cancer, September 1, 2007; 14(3): 901 - 906.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society